HealthEquity, Inc. $HQY Shares Purchased by Hsbc Holdings PLC

Hsbc Holdings PLC lifted its stake in HealthEquity, Inc. (NASDAQ:HQY) by 373.6% in the 1st quarter, HoldingsChannel.com reports. The firm owned 28,181 shares of the company’s stock after acquiring an additional 22,230 shares during the period. Hsbc Holdings PLC’s holdings in HealthEquity were worth $2,361,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of HQY. Acumen Wealth Advisors LLC purchased a new stake in HealthEquity during the 4th quarter worth approximately $27,000. Aster Capital Management DIFC Ltd purchased a new position in shares of HealthEquity in the fourth quarter worth $28,000. Caitong International Asset Management Co. Ltd lifted its stake in shares of HealthEquity by 1,723.5% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock worth $28,000 after buying an additional 293 shares during the period. Leonteq Securities AG lifted its stake in shares of HealthEquity by 159.9% during the first quarter. Leonteq Securities AG now owns 382 shares of the company’s stock worth $32,000 after buying an additional 235 shares during the period. Finally, Torren Management LLC purchased a new stake in shares of HealthEquity during the fourth quarter valued at $40,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at HealthEquity

In other HealthEquity news, Director Gayle Furgurson Wellborn sold 2,439 shares of the business’s stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $219,510.00. Following the completion of the transaction, the director directly owned 19,733 shares of the company’s stock, valued at approximately $1,775,970. The trade was a 11.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 3,142 shares of the company’s stock in a transaction that occurred on Friday, May 29th. The stock was sold at an average price of $95.00, for a total value of $298,490.00. Following the completion of the sale, the executive vice president owned 59,113 shares in the company, valued at approximately $5,615,735. This represents a 5.05% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 17,905 shares of company stock worth $1,651,280. 1.60% of the stock is owned by corporate insiders.

HealthEquity Price Performance

Shares of HQY opened at $94.64 on Friday. The business’s 50-day moving average is $90.21 and its two-hundred day moving average is $84.94. The company has a market capitalization of $7.91 billion, a P/E ratio of 35.45, a P/E/G ratio of 1.59 and a beta of 0.21. The company has a debt-to-equity ratio of 0.46, a quick ratio of 3.44 and a current ratio of 3.44. HealthEquity, Inc. has a fifty-two week low of $72.76 and a fifty-two week high of $105.96.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.11 by $0.13. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The business had revenue of $354.64 million during the quarter, compared to analysts’ expectations of $352.02 million. The company’s revenue for the quarter was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Research analysts predict that HealthEquity, Inc. will post 3.92 earnings per share for the current year.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. Citizens Jmp upped their target price on HealthEquity from $110.00 to $111.00 and gave the company a “market outperform” rating in a research report on Monday, June 1st. Barrington Research reiterated an “outperform” rating and set a $110.00 price target on shares of HealthEquity in a research note on Friday, May 22nd. Wall Street Zen raised HealthEquity from a “hold” rating to a “buy” rating in a report on Saturday. BTIG Research raised their price objective on HealthEquity from $110.00 to $115.00 and gave the stock a “buy” rating in a research note on Friday. Finally, Weiss Ratings raised HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a report on Friday, June 5th. Eleven equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $110.93.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.